Scientific Programme EMUC18, Amsterdam, 8-11 November Friday, 9 November
|
|
|
- Lindsay Parks
- 5 years ago
- Views:
Transcription
1 Scientific Programme EMUC18, Amsterdam, 8-11 November 2018 Friday, 9 November 08:30-08:40 Welcome and introduction Medical oncologist Manuela Schmidinger, Vienna (AT) - ESMO Radiation oncologist Peter Hoskin, Northwood (GB) - ESTRO Urologist Hein Van Poppel, Leuven (BE) - EAU 08:40-10:30 Prostate cancer management: Implementation without good evidence? Urological researcher - Kerstin Junker, Homburg (DE) Urologist - James N Dow, Aberdeen (GB) Radiation oncologist - Bradley Pieters, Amsterdam (NL) 08:40-08:50 Functional imaging for recurrent disease Nuclear medicine - Stefano Fanti, Bologna (IT) 08:50-09:00 Digital GU pathology Pathologist - Rodolfo Montironi, Ancona (IT) 09:00-09:10 High tech radiotherapy Radiation oncologist - Alberto Bossi, Villejuif (FR) 09:10-09:20 Salvage surgery for recurrent disease Urologist - Steven Joniau, Leuven (BE) 09:20-09:30 Sequencing of novel therapies in urogenital malignancies Oncologist - Jörg Beyer, Berlin (DE) 09: How to generate good evidence for 2025? Biostatistician - Laurence Collette, Brussels (BE) :30 Discussion Urologist - James N Dow, Aberdeen (GB) Coffee break and poster viewing 11:00-12:25 Controversies and contradictions in staging of prostate cancer Chairs: Pathologist - Thomas Gevaert, Leuven (BE) Urologist - Igle-Jan De Jong, Groningen (NL) Urologist - Derya Tilki, Hamburg (DE) 11:00-11:20 Predictive statistics applied to diagnosis Statistician - Daniel Sjoberg, New York (US) 11:20-12:25 Multidisciplinary case discussion Case presenter: Urologist Giorgio Gandaglia, Milan (IT) Pathologist - Thomas Gevaert, Leuven (BE) Nuclear medicine - Arturo Chiti, Rozzano (IT) Radiation oncologist - Berardino De Bari, Besancon (FR) Urologist - Jeffrey Karnes, New York (US) Medical oncologist - Stephane Oudard, Paris (FR)
2 12:25-12:45 Update on consensus meetings Chairs: Pathologist - Antonio Lopez-Beltran, Lisbon (PT) Urologist - Jeroen Van Moorselaar, Amsterdam (NL) 12:25-12:35 Update on EAU Prostate Cancer Center consensus meeting Urologist - Peter Albers, Dusseldorf (DE) 12:35-12:45 ECCO-ERQCC Urologist - Maurizio Brausi, Modena (IT) 12:45-14:00 Lunch break and poster viewing (13:00-14:00 Industry session) 14:00-15:30 Immunotherapy: Evolving paradigms in GU cancers Chairs: Pathologist - Maurizio Colecchia, Milan (IT) Urologist - Igle-Jan De Jong, Groningen (NL) Radiation oncologist - Ananya Choudhury, Manchester (GB) 14:00-14:30 Immunotherapy for all patients as first line in kidney cancer? YES Medical oncologist - Laurence Albiges, Villejuif (FR) NO Medical oncologist - Manuela Schmidinger, Vienna (AT) 14:30-14:45 Discussion and questions from the audience 14:45-14:55 Non metastatic MIBCa: Which role for immunotherapy? Medical oncologist - Thomas Powles, London (GB) 14:55-15:10 Metastatic MIBC: When should immunotherapy be used? Medical oncologist - Aristotelis Bamias, Athens (GR) 15:10-15:30 Discussion and questions from audience 15:30-16:00 Coffee break and poster viewing 16:00-17:30 Kidney cancer in the frail patient Chairs: Urologist - Axel Bex, Amsterdam (NL) Urological researcher - Kerstin Junker, Homburg (DE) Pathologist - Gladell Paner, Chicago (US) 16:00-16:20 How to identify the frail patient? Urologist - Umberto Capitanio, Milan (IT) 16:20-17:30 Multidisciplinary case discussion Clinical case by YAU members Urologist - Maria Carmen Mir Maresma, Valencia (ES) Medical oncologist - Joaquim Bellmunt, Boston (US) Nuclear medicine - Stefano Fanti, Bologna (IT) Urologist - Brunolf Lagerveld, Amsterdam (NL) Pathologist - Gladell Paner, Chicago (US)
3 Saturday, 10 November 08:00-10:00 New trials update: What we need to know Chairs: Biostatistician - Laurence Collette, Brussels (BE) Surgical oncologist - Ganesh Palapattu, Ann Arbor (US) Radiation oncologist - Alberto Bossi, Villejuif (FR) 08:00-08:20 Early hormonal manipulation in M0 CRPC Speaker: Medical oncologist - Karim Fizazi, Villejuif (FR) Discussant: Urologist - Thomas Steuber, Hamburg (DE) 08:20-08:40 CARMENA trial Speaker: Urologist - Arnaud Mejean, Paris (FR) Discussant: Urologist - Axel Bex, Amsterdam (NL) 08:40-09:00 POUT trial Speaker: Clinical oncologist - Alison Birtle, Preston (GB) Discussant: Urologist - Evanguelos Xylinas, Paris (FR) 09:00-09:20 STAMPEDE trial Speaker: Radiation oncologist - Nicholas James, Birmingham (GB) Discussant: Urologist - Noel Clarke, Manchester (GB) 09:20-09:40 PRECISION trial Speaker: Urologist - Caroline Moore, London (GB) Discussant: Urologist - Georg Salomon, Hamburg (DE) 09:40-10:00 HORRAD trial Speaker: Urologist - George van Andel, Amsterdam (NL) Discussant: Radiation oncologist - Gert De Meerleer, Leuven (BE) 10:00-10:30 Coffee break and poster viewing 10:30-11:00 Report from new consensus projects Chairs: Radiation oncologist - Berardino de Bari, Besancon (FR) Urologist - Hein Van Poppel, Leuven (BE) 10: EAU-ESMO Bladder Cancer consensus report Urologist - Fred Witjes, Nijmegen (NL) 10:45-11:00 Highlights of Active Surveillance consensus meeting in PCa Urologist - Monique Roobol, Rotterdam (NL) 11:00-11:10 PIONEER session 11:10-12:00 New developments in prostate cancer evaluation Chairs: Pathologist - Rodolfo Montironi, Ancona (IT) Urologist - Henk Van der Poel, Amsterdam (NL) Radiation oncologist - Carl Salembier, Brussels (BE) 11:10-11:35 Everything in prostate cancer pathology you were afraid to ask Speaker: Pathologist - Jonathan I. Epstein, Baltimore (US) Discussant: Urologist - Alberto Briganti, Milan (IT)
4 11:35 12:00 Radiomics: Images are more than pictures Speaker: Radiation oncologist - Philippe Lambin, Maastricht (NL) Discussant: Urologist - Jochen Walz, Marseille (FR) 12:00-12:30 Oral presentation of the 6 best abstracts Urologist - Theo De Reijke, Amsterdam (NL) Radiation oncologist - Thomas Wiegel, Ulm (DE) Announcement 3 best unmoderated posters Urologist - Theo De Reijke, Amsterdam (NL) Radiation oncologist - Thomas Wiegel, Ulm (DE) 12:40-14:00 Lunch break and poster viewing (13:00-14:00 Industry session) 14:00-16:00 BCG refractory disease: Is cystectomy avoidable? Chairs: Urologist - Marek Babjuk, Prague (CZ) Medical oncologist - Susanne Osanto, Leiden (NL) Radiation oncologist - Robert Huddart, Sutton (GB) 14:00-14:15 Mechanisms of action and of resistance to BCG Urologist - George Thalmann, Berne (CH) 14:15-14:30 Pathological variants and predictive markers of BCG response Pathologist - Antonio Lopez-Beltran, Lisbon (PT) 14:30-14:45 Modified BCG trial (SAKK) Urologist - Cyrill Rentsch, Basel (CH) 14:45-15:00 Immunotherapy in NMIBCa Urologist - Morgan Roupret, Paris (FR) 15: Gene therapy Urologist - Colin Dinney, Houston (US) 15:15-15:30 Discussion 15:30-16:00 Case presentation Urologist - Evanguelos Xylinas, Paris (FR) 16:00-16:30 Coffee break and poster viewing 16:30-17:30 Nightmare session: It could happen to you Chairs: Pathologist - Ferran Algaba, Barcelona (ES) Medical oncologist - Susanne Osanto, Leiden (NL) Urologist - Shahrokh Shariat, Vienna (AT) Radiation oncologist - Piet Ost, Ghent (BE) 16:30-16:45 The urologist s nightmare Urologist - Oliver Hakenberg, Rostock (DE) 16:45-17:00 The radiation oncologist s nightmare Radiation oncologist - Gert De Meerleer, Leuven (BE) 17:00-17:15 The medical oncologist s nightmare Medical oncologist - Andrea Necchi, Milan (IT) 17:15-17:30 The pathologist s nightmare Pathologist - Ferran Algaba, Barcelona (ES)
5 Sunday, 11 November 08:30-08:45 Announcement 3 best unmoderated posters Radiologist - Raymond Oyen, Leuven (BE) Radiation oncologist - Bradley Pieters, Amsterdam (NL) Urologist - Michiel Sedelaar, Nijmegen (NL) 08:45-09:00 EAU Research Foundation Urologist - Anders Bjartell, Malmö (SE) 09: Current dilemmas in the management of metastatic prostate cancer Chairs: Urologist - Francesco Montorsi, Milan (IT) 09:00-09:15 Cross-talk between primary and metastatic sites Pathologist - Mark Rubin, New York (US) 09:15-09:30 Cell free DNA in blood: The best source for response prediction? Molecular biologist - Alexander Wyatt, Vancouver (CA) 09:30-09:45 Why some patients get only oligo-metastatic disease? Surgical oncologist - Ganesh Palapattu, Ann Arbor (US) 09:45-10:05 Metastasis directed therapy for oligo-metastatic recurrence YES Radiation oncologist - Piet Ost, Ghent (BE) NO Urologist - Philip Cornford, Liverpool (GB) 10:05-10:25 Selected patients with castration sensitive PCa only require ADT YES Medical oncologist - Stephane Oudard, Paris (FR) NO Urologist - Nicolas Mottet, Saint-Étienne (FR) 10:25-10:45 What is the optimal combination therapy? Abiraterone or docetaxel? Or both? 10:45-11:05 Discussion 11:05-11:50 Take home messages 11:05-11:15 Pathologist - Rodolfo Montironi, Ancona (IT) 11:15-11:25 Radiation oncologist - Anne Kiltie, Oxford (GB) 11:25-11:35 Urologist - Evanguelos Xylinas, Paris (FR) 11:35-11:45 11:45-11:55 Medical oncologist - Laurence Albiges, Villejuif (FR) 11:55-12:00 Closing remarks Medical Oncologist - Aristotelis Bamias, Athens (GR) - ESMO - ESTRO Urologist - Hein Van Poppel, Leuven (BE) - EAU
Scientific Programme EMUC18, Amsterdam, 8 11 November Friday, 9 November
Scientific Programme EMUC18, Amsterdam, 8 11 November 2018 Friday, 9 November 08:30-08:40 Welcome and introduction Medical oncologist Manuela Schmidinger, Vienna (AT) - ESMO Radiation oncologist Peter
Scientific Programme EMUC18, Amsterdam, 8-11 November Friday, 9 November
Scientific Programme EMUC18, Amsterdam, 8-11 November 2018 Friday, 9 November 08:30-08:40 Welcome and introduction Medical oncologist Manuela Schmidinger, Vienna (AT) - ESMO Radiation oncologist Peter
9th European Multidisciplinary Meeting on Urological Cancers (EMUC17) Multidisciplinary strategies in urogenital cancers
9th European Multidisciplinary Meeting on Urological Cancers (EMUC17) Multidisciplinary strategies in urogenital cancers Friday, 17 November 08.15-08.20 Welcome and Introduction Medical oncologist Thomas
9th European Multidisciplinary Meeting on Urological Cancers (EMUC17) Multidisciplinary strategies in urogenital cancers
9th European Multidisciplinary Meeting on Urological Cancers (EMUC17) Multidisciplinary strategies in urogenital cancers Friday, 17 November 08.15-08.20 Welcome and Introduction Medical oncologist Thomas
High risk non-muscle invasive bladder cancer: From guidelines to future approaches Chairs: A. Lopez Beltran, Lisbon (PT)
Friday, 8 June 2018 EAU Update on Bladder Cancer (BCa18) Challenging your knowledge of the EAU Guidelines 8-9 June 2018, Munich, Germany Steering committee: F. Montorsi, H. Van Poppel and M. Wirth Scientific
ESOU programme Prostate cancer screening: Why screening programme should not be adopted in > 65 A. Heidenreich, Aachen (DE)
Friday, 17 January 08.30-08.40 Welcome M. Babjuk, Prague (CZ) M. Brausi, Modena (IT) 08.40-09.00 Opening address ESOU programme 09.00-11.00 Prostate cancer I: Screening, diagnosis, staging and treatment
Scientific Programme
Scientific Programme Friday, 18 January 08.30 08.40 Welcome M.Brausi, Modena (IT) M. Babjuk, Prague (CZ) 08.40 08.55 Opening address History and impact of ESOU in onco urology M. Brausi, Modena (IT) 08.55
ESUI17. Programme Book. General Information. 9th European Multidisciplinary Meeting on Urological Cancers
General Information Programme Book ESUI17 Implementing multidisciplinary strategies in genito-urinary cancers 16-19 November 2017, Barcelona, Spain 6th Meeting of the EAU Section of Urological Imaging
Saturday, 13 February 2016
Saturday, 13 February 2016 16.10 16.15 Opening and welcome C.R. Chapple, Sheffield (GB) 16.15 18.00 What is new in urology 1 Chairs: C. R. Chapple, Sheffield (GB) 16.15 16.35 Functional urology C. Gratzke,
Programme - Friday, 7 September
Programme - 15th Meeting of the EAU Robotic Urology Section Room: Auditorium Actual programme might be subject to change due to live surgery Live broadcasts from Institut Paoli-Calmettes and Hôpital Nord,
6 th Meeting of the European Society of Oncological Urology (ESOU)
6 th Meeting of the European Society of Oncological Urology (ESOU) 16-18 January 2009, Istanbul, Turkey ESOU is a full member of the EAU Section Office European Association of Urology Contents Welcome
Programme - Wednesday, 5 September
Programme - Wednesday, 5 September 15th Meeting of the EAU Robotic Urology Section Room: Auditorium Actual programme might be subject to change due to live surgery Live broadcasts from Institut Paoli-Calmettes
Auditorium. Title: Welcome and Introduction by the Chairs Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES
08-04-2017 12:45-13:00 Type: Educational session Title: Welcome and Introduction by the Chairs 1 2 1 2 Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES 12:45-13:00 Welcome 13:00-13:15
Scientific Programme
Scientific Programme Thursday, 12 October 2017 10.00 14.30 Registration 12.00 14.00 ESU Course Clinical and histopathological basics in bladder cancer: unmet needs Chair : Bernard Malavaud, Toulouse (FR)
Thursday 15 September
Thursday 15 September 07.45 08.00 Welcome EAU and Chair Host Faculty ERUS Chair Host Faculty Chair Host Faculty F. Montorsi, Milan (IT) A. Mottrie, Aalst (BE) G. Guazzoni, Milan (IT) 08.00 08.10 Outcome
Scientific Programme
Scientific Programme Thursday, 4 October 2018 10.00 14.30 Registration 12.00 14.00 ESU Course Clinical and histopathological basics and main research questions in prostate cancer Chair : M. Sedelaar, Nijmegen
Berlin. Title: Industry Satellite Symposium. Vienna. Title: Industry Satellite Symposium. Exhibition area. Title: Welcome reception
02.05.2019 12:00-13:00 Type: Industry Satellite Symposium 12:00-13:00 Type: Industry Satellite Symposium 13:00-13:30 Type: Opening session Title: Welcome reception Exhibition area 13:30-13:45 Type: Opening
URO-ONCOLOGY DIALOGUE
10 th Annual Princess Margaret Cancer Centre URO-ONCOLOGY DIALOGUE Ontario Community and Academic Urologist Dialogue PROGRAM #PMCC18 Queen s Landing Niagara-on-the-Lake, ON September 14-16, 2018 We would
Friday 25 May EAU Lecture Where are we in male infertility in 2018? J.O.R. Sonksen, Herlev (DK)
Friday 25 May 2018 08.45 09.00 Welcome M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) A. Strotsky, Minsk (BY) C.R. Chapple, Sheffield (GB) 09.00 09.30 EAU Lecture Where are we in male infertility in 2018?
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme 14-19 July 2016, Valencia, Spain Co-chairs: Andrés Cervantes, ES - Nicholas Pavlidis, GR - Susana Banerjee, UK Thursday, 14
Moderation: S. Rauh, D. Arnold ; Esch, LU, Lisbon, PT. Moderation: S. Rauh, Esch, LU
03-03-2017 13:30-13:45 Opening and welcome Auditorium Moderation: S. Rauh, D. Arnold ; Esch, LU, Lisbon, PT 13:30-13:45 Welcome to the Conference 13:45-14:15 Keynote lecture Auditorium Moderation: 13:45-14:15
Management of Prostate Cancer
Management of Prostate Cancer Michel Bolla Hendrik van Poppel Editors Management of Prostate Cancer A Multidisciplinary Approach Second Edition Editors Michel Bolla Department of Radiation Oncology Hôpital
S. Rauh 1, J. Douillard 2 ; 1 Esch Sur Alzette, LU, 2 Lugano - Viganello, CEDEX/CH
27.04.2018 10:30-10:45 Opening and welcome Sala B Moderation: S. Rauh, J. Douillard ; Esch Sur Alzette, LU, Lugano - Viganello, CEDEX/CH 10:30-10:45 Welcome to the Symposium S. Rauh 1, J. Douillard 2 ;
THE PSA AND PROSTATE CANCER DILEMMA
IV CLINICAL UROLOGY MEETING THE PSA AND PROSTATE CANCER DILEMMA BILBAO February 23-24, 2017 Clínica IMQ Zorrotzaurre Organized by: SOME REASONS TO ATTEND OUR MEETING The PSA test is not a prostate cancer
ESSO Advanced Course on Primary Liver Tumours
ESSO Advanced Course on Primary Liver Tumours 24-25 April 2014 LIVERPOOL (UK) Endorsed by ESSO Advanced Course on Primary Liver Tumours Chair Hassan Malik, University Hospital Aintree NHS Trust, Liverpool,
Thursday 19 October 2017
Thursday 19 October 2017 08.15 10.00 International part of the Czech Meeting in cooperation with EAU 17 th CEM (Big hall) (Lectures and discussions in English) 08.15 08.35 Welcome by CUS and EAU executive
S. Rauh 1, J. Douillard 2 ; 1 Esch Sur Alzette, LU, 2 Lugano - Viganello, CEDEX/CH
27.04.2018 10:30-10:45 Opening and welcome Sala B Moderation: S. Rauh, J. Douillard ; Esch Sur Alzette, LU, Lugano - Viganello, CEDEX/CH 10:30-10:45 Welcome and introduction S. Rauh 1, J. Douillard 2 ;
UPDATE ON RECENT CUTTING-EDGE TRIALS: TREATMENTS NOW AVAILABLE FOR NEWLY DIAGNOSED mhspc PATIENTS
UPDATE ON RECENT CUTTING-EDGE TRIALS: TREATMENTS NOW AVAILABLE FOR NEWLY DIAGNOSED mhspc PATIENTS Dr. Neal Shore, Carolina Urologic Research Centre, USA Assoc. Prof. Neeraj Agarwal, Huntsman Cancer Institute,
Monday, 5 February 2018
Educational sessions for Junior audience Monday, 5 February 2018 09:30-11:00 Session 1 The diseases Chairs: Paolo. G Casali, IT; Paula Collini, IT 25 The natural history of STS & GIST Paolo. G Casali,
James Catto, UK. Giacomo Novara, Italy Jean-Nicolas Cornu, France. Alexander Kutikov, USA. Karim Fizazi, France. Leila Ayandi, UK
EDITOR EMERITUS (1975 2005) Claude Schulman, Belgium EDITOR EMERITUS (2006 2013) Francesco Montorsi, Italy EDITOR-IN-CHIEF James Catto, UK Christian Gratzke, Germany Matthew Cooperberg, USA ASSOCIATE EDITORS
Information for Patients. Prostate cancer. English
Information for Patients Prostate cancer English Table of contents What is prostate cancer?... 3 The role of hormones in prostate cancer cell growth... 3 Stages of the disease... 3 Risk factors for prostate
January 10-12, Westin Harbour Castle Toronto, ON #CUOS19. cuos2019.org
January 10-12, 2019 Westin Harbour Castle Toronto, ON #CUOS19 cuos2019.org Scientific Program Committee Co-Chairs: Neil Fleshner, CUOG Aly-Khan Lalani, GUMOC Himu Lukka, GUROC Andy Evans, CNUP Tony Finelli,
Diagnosis and Classification of Prostate Cancer
Patient Information English 32 Diagnosis and Classification of Prostate Cancer The underlined terms are listed in the glossary. prostate biopsy is the only test that can confirm a prostate cancer diagnosis.
ESSO Advanced Course on Breast Cancer Surgery
ESSO Advanced Course on Breast Cancer Surgery 08-10 October 2015 LISBON In Partnership with ESSO Advanced Course on Breast Cancer Surgery Chairs Marjut Leidenius, Helsinki University Central Hospital,
ONCOLOGY NURSING 9 TH ESO-EONS MASTERCLASS IN March 2016 Ermatingen (Lake Constance) Switzerland #16MON
MASTERCLASS Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans 9 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING 12-17 March 2016 Ermatingen
Beyond FDG: International Symposium on PET Tracers in Oncology
Second announcement Beyond FDG: International Symposium on PET Tracers in Oncology Presymposium workshop, April 2 nd Date April 3 rd and 4 th, 2014 Location University Medical Center Groningen, Groningen,
Friday, 24 October 2014
PRELIMINARY PROGRAMME Friday, 24 October 2014 08.00 08.10 Welcome 08.10 08.15 Opening 08.15 08.35 EAU Lecture Cystectomy in female A. Stenzl, Tübingen 08.35 10.00 Debate 1 Small renal masses: from radical
Program 12 th Meeting of the IBCN September th, 2014, Vancouver, Canada
THURSDAY, SEPTEMBER 25 TH, 2014 19.00 Welcome Dinner Cactus Club, Yaletown (357 Davie St) FRIDAY, SEPTEMBER 26 TH, 2014 Introduction Topic Speaker 07:30 08:00 Registration/Light breakfast 08:00 08:15 Welcome
THURSDAY, DECEMBER 13, 2018
THURSDAY, DECEMBER 13, 2018 7:00 am Welcome and Introduction 7:10 am The Hans E. Shapira Lecture Prostate Cancer: A Perspective; the Right Treatment for the Right Patient at the Right Time Peter Scardino,
Residual Cancer. May 3-5, International Symposium. on Minimal. Le Corum. > Preliminary. Program MONTPELLIER, FRANCE
International Symposium th on Minimal Residual Cancer > Preliminary Program May 3-5, 2018 Le Corum MONTPELLIER, FRANCE Organizers: www.ismrc2018.com > Committee & Speakers > Welcome to Montpellier Scientific
CRC 992 Symposium on Medical Epigenetics 2018
CRC 992 Symposium on Medical Epigenetics 2018 Monday, March 12 th Wednesday, March 14 th Agenda Lecture Hall Otto-Krayer-Haus Albertstr. 25 79104 Freiburg, Germany Day 1 Monday, March 12 th 2018, 14:30-19:30
2014 Patient Track Program
2014 Patient Track Program Saturday 27 September 2014 PART1: 10:00-13:00 Cancer Research 10:00-10:45 Clinical trials: making statistics a little bit easier to understand! Anastassia Negrouk, Brussels,
ROOM: CONRAD + ARNOLD. ROOM: CONRAD + ARNOLD Focus on ESO, ESMO and EONS Nicholas Pavlidis, Rolf Stahel,
17h ESO-ESMO Masterclass in Clinical Oncology 24-29 March 2018, Berlin, Germany In collaboration with the Flims Alumni Club Chair: Nicholas Pavlidis, GR and Rolf A. Stahel, CH Scientific Advisors: R. Popescu,
Day 1: ESMO Sarcoma & GIST Faculty closed meeting
Day 1: ESMO Sarcoma & GIST Faculty closed meeting Sunday, 4 February 2018 12:30 14:00 Lunch 14:00-16:00 Discussion: Should we routinely use NGS? 120 Panel discussion 16:00 16:30 Coffee Break 16:30-18:00
ESMO SUMMIT AFRICA Practice changing studies in Prostate Cancer in 2016 and 2017 and cost-effectiveness Ronald de Wit
ESMO SUMMIT AFRICA 2018 Practice changing studies in Prostate Cancer in 2016 and 2017 and cost-effectiveness Ronald de Wit CONFLICT OF INTEREST DISCLOSURE Sub-title Sanofi Roche Merck Lilly 14 years of
Updates in Prostate Cancer Treatment 2018
Updates in Prostate Cancer Treatment 2018 Mountain States Cancer Conference Elaine T. Lam, MD November 3, 2018 Learning Objectives Understand the difference between hormone sensitive and castration resistant
ESMO Symposium on Immuno-Oncology Programme book
IMMUNO-ONCOLOGY SYMPOSIUM ESMO Symposium on Immuno-Oncology Programme book Advances in cancer immunotherapy; From vaccines to antibodies and cell therapies Geneva Switzerland 15-16 NOVEMBER 2013 esmo.org
SCOTTISH ONCOLOGY SUMMIT Double Tree by Hilton, Dunblane Hydro, Dunblane 1 st - 2 nd September 2017
Friday 1 st September 1300h 1400h Lunch (arrival, registration at conference foyer, coffee and sponsors exhibition) 1400h 1420h Prof Robert Jones Welcome/Announcements 1430h 1600h Parallel sessions: Lung
First AUBMC Theranostics Conference: See What You Treat
The Division of Nuclear Medicine, PET/CT and Cyclotron Facilities, Department of Diagnostic Radiology, AUBMC presents the First AUBMC Theranostics Conference: See What You Treat Endorsed by the International
Frequently Asked Questions about Prostate Cancer. General questions. Patient Information. What is prostate cancer?
Patient Information English Frequently Asked Questions about Prostate Cancer The underlined terms are listed in the glossary. General questions What is prostate cancer? Prostate cancer is a malignant tumour
Juravinski Cancer Centre Uro-Oncology Forum April 13-14, 2018 Pillar & Post Inn Niagara-on-the-Lake, ON #JCC18.
Juravinski Cancer Centre Uro-Oncology Forum 2018 April 13-14, 2018 Pillar & Post Inn Niagara-on-the-Lake, ON #JCC18 Final Program STEERING COMMITTEE, Chair Sebastien Hotte Himu Lukka Bobby Shayegan The
oncology For 9 th eso-esmo course on July 2012 ioannina, Greece
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA ioannina 21/07/12 9 th eso-esmo course on oncology For medical students 21-27 July 2012 ioannina, Greece chair: N. Pavlidis, GR core faculty: R.A. Audisio, UK
10 th ESO-EONS MASTERCLASS IN ONCOLOGY NURSING march 2017 nauen ot Groß Behnitz (Berlin area), Germany. masterclass
10 th ESO-EONS MASTERCLASS IN ONCOLOGY NURSING 25-30 march 2017 nauen ot Groß Behnitz (Berlin area), Germany Chairs: B. Grube, DK - C. Lacerda, PT Coordinator: E. van Muilekom, NL Advisor: masterclass
CLINICAL ONCOLOGY March 2012 Ermatingen (Lake Constance), Switzerland
MASTERCLASS ERMATINGEN 17/03/12 11 TH ESO-ESMO MASTERCLASS IN CLINICAL ONCOLOGY 17-22 March 2012 Ermatingen (Lake Constance), Switzerland Chairs: N. Pavlidis, GR - R.A. Stahel, CH Scientific Co-ordinators:
Oligometastasis. Körperstereotaxie bei oligo-metastasiertem Prostatakarzinom wann und wie in Kombination mit Systemtherapie?
Körperstereotaxie bei oligo-metastasiertem Prostatakarzinom wann und wie in Kombination mit Systemtherapie? Daniel M. Aebersold 09. Dezember 2016 Oligometastasis JCO, 1995 1 Oligometastasis: Chance for
Heart Failure Association. Mitochondria and Metabolism Targets for the Treatment of Heart Failure
Heart Failure Association HFA Translational Research Workshop 2012 of the European Society of Cardiology Translational Research Workshop 2012 Mitochondria and Metabolism Targets for the Treatment of Heart
3. ITLT Essen 2013 Interdisciplinary Treatment of Liver Tumors April 18-20, 2013 Essen, Germany
3. ITLT Essen 2013 Interdisciplinary Treatment of Liver Tumors April 18-20, 2013 Essen, Germany Scientific Program Thursday, 18th April 2013 HR Thursday, 18th April 08:00 Breakfast Symposia 09:00 Registration
in Laparoscopy The European Congress of Laparoscopy 2007 Bordeaux, France Palais des Congres
Challenges 2007 in Laparoscopy The European Congress of Laparoscopy 2007 Some of the most prominent Laparoscopic Urological Surgeons will perform innovative live surgery demonstrating the full spectrum
PDX MODELS IN CLINICAL ONCOLOGY AND CANCER PRECISION MEDICINE 3-5 OCTOBER Seminar-Hotel Rigi am See Weggis Switzerland
PDX MODELS IN CLINICAL ONCOLOGY AND CANCER PRECISION MEDICINE 3-5 OCTOBER 2016 Seminar-Hotel Rigi am See Weggis Switzerland Scientific Programme Each speaker in the programme will be careful to allow enough
Advanced Prostate Cancer Consensus Conference (APCCC) 2017 in St. Gallen : Defining best Practice in Routine Care
Advanced Prostate Cancer Consensus Conference (APCCC) 2017 in St. Gallen : Defining best Practice in Routine Care Silke Gillessen Medical Oncology Kantonsspital St. Gallen Switzerland Conflicts of interest
OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February
Organized by Valencia, 22 nd February 2019 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update DIRECTORS Andrés Poveda Initia Oncology, Hospital Quirónsalud, Valencia, Spain Jan
PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018
PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, 2018 16 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 12-15, 2018 Friday, January 12, 2018 Registration:
CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves Douillard, France
ESMO Preceptorship Programme Colorectal Cancer Multidisciplinary management, standards of care and future perspectives Prague, Czech Republic 6-7 July 2016 CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves
Salvage Cryotherapy. Bernard Malavaud MD, PhD, FEBU Institut Universitaire du Cancer Toulouse (France)
Urethra protection Argon decompression -40 /-60 C 17G hollow needles Salvage Cryotherapy Ice all TRUS positioning & monitoring temperature monitoring of the rectal wall ernard Malavaud MD, PhD, FEU Institut
ROTTERDAM 12/01/12 ACTIVE SURVEILLANCE FOR LOW RISK PROSTATE CANCER January 2012 Rotterdam, The Netherlands
ESO INSIDE TRACK CONFERENCE ROTTERDAM 12/01/12 ACTIVE SURVEILLANCE FOR LOW RISK PROSTATE CANCER 12-13 January 2012 Rotterdam, The Netherlands Chair: C.H. Bangma, NL - L. Klotz, CA Co-Chair: L.J. Denis,
THURSDAY, DECEMBER 13, 2018
THURSDAY, DECEMBER 13, 2018 7:00-7:10am 7:10-7:15am 7:15-7:45am Welcome and Introduction Audience Response Question with App Orientation Ketan K. Badani, MD The Hans E. Shapira Lecture Prostate Cancer:
Gastric Cancer Co-Chairs Speakers LEARNING OBJECTIVES
ESMO Preceptorship Programme Gastric Cancer Multidisciplinary management, standards of care, therapeutic targets and future perspectives 10-11 June 2016, Prague, Czech Republic Co-Chairs Andres Cervantes
Glossary of Terms Prostate Cancer
Patient Information English Glossary of Terms Prostate Cancer Active surveillance A form of treatment in which the doctor actively monitors the tumour or tumours and their growth, based on a strict visiting
International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY
International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY A Joint Initiative of IAEA BELNUC - JULES BORDET INSTITUTE OCTOBER 2-6, 2017 Venue: Auditorium Tagnon Jules Bordet Institute Boulevard de
Clinical. Update in Respiratory Medicine. International Symposium on. Barcelona (Spain) February 23 rd -24 th, 2018 FINAL PROGRAMME
With an unrestricted grant by Organized by Vall d Hebron Barcelona Hospital Campus Barcelona, Spain International FINAL PROGRAMME Respiratory diseases are among the most frequent causes of mortality and
Incorporating New Agents into the Treatment Paradigm for Prostate Cancer
Incorporating New Agents into the Treatment Paradigm for Prostate Cancer Dr. Celestia S. Higano FACP, Professor, Medicine and Urology, Uni. of Washington Member, Fred Hutchinson Cancer Research Center
PSA SCREENING FOR PROSTATE CANCER
Policy Paper on PSA SCREENING FOR PROSTATE CANCER Has the time come to reconsider structured population-based PSA screening for prostate cancer? 1 2 Table of contents Table of Contents 1 EXECUTIVE SUMMARY
Multidisciplinary Genitourinary Oncology Course:
Taussig Cancer Institute and Glickman Urological Institute present Multidisciplinary Genitourinary Oncology Course: Focus on Kidney, Bladder, and Testicular Cancer Thursday, December 14, 2017 Cleveland,
ESO-ASCO MASTERCLASS IN CLINICAL ONCOLOGY November 2018 Yerevan, Armenia MASTERCLASS
ESO-ASCO MASTERCLASS IN CLINICAL ONCOLOGY 10-13 November 2018 Yerevan, Armenia Chairs: G. Curigliano, IT F. Peccatori, IT Host Chair: G. Tamamyan, AM Held in collaboration with MASTERCLASS AIMS AND OBJECTIVES
Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)
ESTRO Teaching Course on Image-guided radiotherapy & chemotherapy in gynaecological cancer - With a special focus on adaptive brachytherapy Prague, Czech Republic 22-26 October 2016 Course Directors: Richard
8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC)
Sezione di Oncologia [ Meet the Professor ] 8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC) November 15-17, 2012 The Conference will include: 1) Lectures: Internationally recognized
Joelle Hamilton, M.D.
Joelle Hamilton, M.D. www.urologycentersalabama.com Case Presentation: CRPC, Rising PSA 70 yo healthy, fit, active man post RALP 8 years prior with rising PSA Rising PSA from 0.02 nadir to 3.4 thus ADT
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Targeted Cancer Therapy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Targeted Cancer Therapy April 26-29, 2012 Villa La Collina Cadenabbia (Co), Italy Program Committee Cathrin Brisken, Lausanne (Chair)
8 th course on NON-CODING GENOME February 13-20, 2019 Institut Curie - Training Unit - International Course
Wednesday, February 13 Non-coding genome and pervasive transcription Chairs: Antonin Morillon Sven Diederichs 11.30 12.30 Registration & LUNCH (sandwiches) 12.30 13.00 13.00 14.00 14.00 15.00 Antonin MORILLON
Prostate cancer: For Decision Making april 7-9, 2011 Memorial sloan-kettering cancer center new York, US
A CME CONFERENCE JOINTLY SPONSORED BY: new York 04/07/11 2 nd interdisciplinary conference Prostate cancer: PreDictiVe MoDels For Decision Making april 7-9, 2011 Memorial sloan-kettering cancer center
Royal Marsden Testicular and Bladder Cancer Meeting Improving Outcomes with Multidisciplinary Care
The Royal Marsden Conference Team Royal Marsden Testicular and Bladder Cancer Meeting Improving Outcomes with Multidisciplinary Care Friday 14th October 2016 The Royal Marsden Conference Centre, Stewart
4th ESSO Advanced Course on the Management of Colorectal Liver Metastases
4th ESSO Advanced Course on the Management of Colorectal Liver Metastases 10-11 October 2016 BORDEAUX (FR) 4 th ESSO Advanced Course on the Management of Colorectal Liver Metastases Chairs Serge Evrard,
January 10-12, Westin Harbour Castle Toronto, ON #CUOS19. cuos2019.org
January 10-12, 2019 Westin Harbour Castle Toronto, ON #CUOS19 cuos2019.org Scientific Program Committee Co-Chairs: Neil Fleshner, CUOG Aly-Khan Lalani, GUMOC Himu Lukka, GUROC Andy Evans, CNUP Tony Finelli,
MEETING 2NEW STRATEGIES KIDNEY CANCER TREATMENT AND TRANSPLANT SURGERY. Rome September 28-30, 2015 POLICLINICO TOR VERGATA FOUNDATION ROME, ITALY
2NEW STRATEGIES MEETING FOR nd Rome September 28-30, 2015 POLICLINICO TOR VERGATA FOUNDATION ROME, ITALY Organizing Secretariat: I.D.S. SpA tel. +39 06 4505503-06 41792581 - info@itrusturology.com KIDNEY
Francesco Massari Oncologia Medica Azienda Ospedaliero Universitaria di Bologna Policlinico S. Orsola-Malpighi
Focus sulla malattia metastatica ormonosensibile (mhspc) ADT e Chemioterapia: quando e a chi? Francesco Massari Oncologia Medica Azienda Ospedaliero Universitaria di Bologna Policlinico S. Orsola-Malpighi
Neuromuscular Pathology
Neuromuscular Pathology working group Chair: Bjarne Udd, Tampere, FI Co-chair: Anders Oldfors, Gothenburg, SE Patient representative: Massimo Mara, IT Members: - Norma Romero, Paris, FR - Werner Stenzel,
Selected topics in tumors of the kidney and urothelium
European Society of Pathology Serbian Association for Pathology Serbian Association of Urologists Serbian Association of Pathologists and Cytologists Belgrade Medical School Serbian Scientific Society
Session 4 Chemotherapy for castration refractory prostate cancer First and second- line chemotherapy
Session 4 Chemotherapy for castration refractory prostate cancer First and second- line chemotherapy October- 2015 ESMO 2004 October- 2015 Fyraftensmøde 2 2010 October- 2015 Fyraftensmøde 3 SWOG 9916 OS
Non-systemic treatment of low-volume metastatic disease.
Non-systemic treatment of low-volume metastatic disease. Gert De Meerleer, M.D., Ph.D. Gent University Hospital om behalf of POMP study group Background Patients with metastatic prostate cancer are considered
Challenging Genitourinary Tumors: What s New in 2017
Challenging Genitourinary Tumors: What s New in 2017 David J. Vaughn, MD Genitourinary Medical Oncology Professor Please note that some of the studies reported in this presentation were presented as an
FRIDAY, DECEMBER 14, 2018
FRIDAY, DECEMBER 14, 2018 7:00 am Day Two Welcome Ash Tewari, MBBS, MCh RADICAL PROSTATECTOMY Panelists: Arul Chinnaiyan, MD, PhD; Douglas Scherr, MD; Prasanna Sooriakumaran, MD, PhD; Ofer Yossepowitch,
PAUL PETERS 2018 PROGRAM. 9:20am Reconstructive Urology Case Discussion Maxim McKibben MD, Joceline Fuchs MD, Allen Morey MD (moderator)
PAUL PETERS 2018 PROGRAM Friday January 19, 2018 8:00am - Registration and breakfast 8:30am Chairman Introduction: Claus Roehrborn, MD Reconstruction 9:00am Prosthetic Urology Update 2018 Allen Morey MD
International Workshop of Sex Development and Maturation
A systematic elucidation of Differences of Sex Development COST-Action BM1303 www.dsdnet.eu Preliminary Programme International Workshop of Universität zu Lübeck Germany In collaboration with RESULTS AND
Focus sulla malattia metastatica ormonosensibile (mhspc) ADT e Terapia ormonale: quando e a chi?
Focus sulla malattia metastatica ormonosensibile (mhspc) ADT e Terapia ormonale: quando e a chi? Paolo Andrea Zucali Dipartimento di Oncologia HUMANITAS CANCER CENTER Rozzano - Milano AGENDA Literature
ASKLEPIOS Course MULTIDISCIPLINARY APPROACH TO CANCER IMAGING. Education in partnership. November 5 6, 2018 Rome/Italy. myesr.
ASKLEPIOS Course APPROACH TO CANCER IMAGING Education in partnership myesr.org/esor myesr.org/esor ASKLEPIOS Course APPROACH ASKLEPIOS Course Course information This course is designed for radiologists,
State-of-the-art: vision on the future. Urology
State-of-the-art: vision on the future Urology Francesco Montorsi MD FRCS Professor and Chairman Department of Urology San Raffaele Hospital Vita-Salute San Raffaele University Milan, Italy Disclosures
ADVANCES IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER. ALICIA K. MORGANS, MD, MPH Associate Professor of Medicine Northwestern University, USA
ADVANCES IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER ALICIA K. MORGANS, MD, MPH Associate Professor of Medicine Northwestern University, USA MAY 2018 DISCLAIMER Please note: The views expressed within
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy Program Committee Martin Schuler, Essen (Chair) Cathrin Brisken,